Literature DB >> 34273289

Sleep and liver disease: a bidirectional relationship.

Thomas Marjot1, David W Ray2, Felicity R Williams3, Jeremy W Tomlinson2, Matthew J Armstrong4.   

Abstract

Sleep is a complex, highly regulated process essential for human health and wellbeing. Increasingly, sleep-wake disturbance has been implicated in the pathogenesis of chronic liver disease, particularly the development and progression of non-alcoholic fatty liver disease and alcohol-related liver disease. Patients with cirrhosis also have a high burden of sleep abnormalities with substantial implications for their quality of life and physical health. This Review summarises the epidemiology and pathophysiology of sleep-wake disturbance in liver disease and discusses the multiple converging pathways leading to abnormal sleeping patterns in patients with cirrhosis. This includes contributions from altered melatonin metabolism, neuromuscular complications, and aberrant thermoregulation. In turn, a vicious cycle is established whereby disrupted sleep can further contribute to liver disease progression. We also begin to unravel the complex, interlinking relationship between sleep-wake disturbance and hepatic encephalopathy, discussing both overlapping and distinct mechanisms and clinical features. Finally, we summarise the current and future therapeutic approaches aiming to improve sleep quality in patients with cirrhosis.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2021        PMID: 34273289     DOI: 10.1016/S2468-1253(21)00169-2

Source DB:  PubMed          Journal:  Lancet Gastroenterol Hepatol


  5 in total

1.  Symptom control in advanced chronic liver disease: integrating anticipatory palliative and supportive care.

Authors:  Mark Wright; Hazel Woodland; Ben Hudson
Journal:  Frontline Gastroenterol       Date:  2022-06-01

2.  Associations of Multiple Serum Trace Elements with Abnormal Sleep Duration Patterns in Hospitalized Patient with Cirrhosis.

Authors:  Yangyang Hui; Gaoyue Guo; Lihong Mao; Yifan Li; Mingyu Sun; Xiaoyu Wang; Wanting Yang; Xiaofei Fan; Kui Jiang; Binxin Cui; Chao Sun
Journal:  Biol Trace Elem Res       Date:  2022-09-22       Impact factor: 4.081

3.  The role of REV-ERB in NASH.

Authors:  Kristine Griffett; Matthew E Hayes; Michael P Boeckman; Thomas P Burris
Journal:  Acta Pharmacol Sin       Date:  2022-02-25       Impact factor: 7.169

4.  Association between sleep duration and albumin in US adults: a cross-sectional study of NHANES 2015-2018.

Authors:  Jingxian Li; Lizhong Guo
Journal:  BMC Public Health       Date:  2022-06-02       Impact factor: 4.135

Review 5.  Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future.

Authors:  João Paulo Margiotti Dos Santos; Mariana Canevari de Maio; Monike Alves Lemes; Lucas Fornari Laurindo; Jesselina Francisco Dos Santos Haber; Marcelo Dib Bechara; Pedro Sidnei do Prado; Eduardo Costa Rauen; Fernando Costa; Barbara Cristina de Abreu Pereira; Uri Adrian Prync Flato; Ricardo de Alvares Goulart; Eduardo Federighi Baisi Chagas; Sandra Maria Barbalho
Journal:  Int J Mol Sci       Date:  2022-01-02       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.